Walgreens beats estimates in fiscal Q2

Walgreens Boots Alliance Inc is trading up in premarket on Thursday after reporting upbeat financial results for its second quarter. Walgreens' guidance for the full year Investors are cheering als...

Walgreen's stock gains after big profit beat, while full-year outlook was lowered

Shares of Walgreens Boots Alliance Inc. WBA, +2.49% gained 0.8% in premarket trading Thursday after the drugstore chain reported fiscal second-quarter adjusted profit and sales that rose well above...

Walgreens narrows full-year profit forecast and takes $5.8 billion impairment

Walgreen Boots Alliance narrowed its profit forecast for fiscal 2024 by on Thursday, citing economic challenges for its retail business, and also took a $5.8 billion impairment related to its Villa...

Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours

Walgreens Boots Alliance lost nearly $6 billion in its second quarter as the company grapples with the loss in value of its investment in doctor-staffed clinic operator VillageMD.

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy

Walgreens posted a steep net loss for the quarter as it recorded a hefty goodwill impairment charge related to its primary-care provider VillageMD.

Walgreens Earnings, US Eco Data, SBF Sentencing | What We're Watching

Walgreens Earnings, US Eco Data, SBF Sentencing and much more coming tomorrow.

Walgreens Earnings Are Thursday. Investors Want to See Changes.

The retail pharmacy chain reports results before the market open Thursday.

Walgreens Boots to reveal new CEO strategy in trading update

Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A), the retail pharmacist, will likely showcase how its strategy is evolving under newly appointed CEO Tim Wentworth at its second quarter update on ...

Countdown to Walgreens (WBA) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Walgreens (WBA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for th...

Jim Cramer's week ahead: New consumer data and earnings from Walgreens

CNBC's Jim Cramer on Friday guided investors through next week's most important happenings on Wall Street.

Walgreens' Strategic Pivot

Walgreens Boots Alliance, Inc. faces challenges in its retail pharmacy business due to lower demand for COVID-19 testing and tight prescription drug payouts. The company is transitioning into a hea...

Earnings Preview: Walgreens Boots Alliance (WBA) Q2 Earnings Expected to Decline

Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Walgreens' (WBA) AllianceRx Pharmacy Will Distribute VIVJOA

Walgreens' (WBA) specialty pharmacy patients now have exclusive access to 240+ limited distribution drugs.

Walgreens Consolidating Distribution In Latest Restructuring Move

Walgreens Boots Alliance chief executive officer Tim Wentworth is continuing his effort to turn around the drugstore chain by consolidating its massive distribution network.

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Sentiment surrounding Walgreens Boots Alliance has reached a negative extreme among both Main Street and Wall Street analysts. The stock's exit from the Dow may lead to temporary downsides, but lon...


Related Companies

Track Institutional and Insider Activities on WBA

Follow Walgreens Boots Alliance, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WBA shares.

Notify only if

Insider Trading

Get notified when an Walgreens Boots Alliance, Inc. insider buys or sells WBA shares.

Notify only if

News

Receive news related to Walgreens Boots Alliance, Inc.

Track Activities on WBA